NATAP HEPATITIS & TRANSPLANT UPDATES

[Guest guest]

NATAP - www.natap.org

NATAP HEPATITIS & TRANSPLANT UPDATES: the latest information & studies in hepatitis C & B

HEPATITIS C-

http://www.natap.org/hcv.htm

1. ViroPharma Announces Start of HCV-796 Phase 1 Program - (02/15/05)

2. Hepatitis B or Hepatitis C and HIV-infection Diagnosis/Care/Treatent - (02/11/05)

3. Study Finds Interferon Reduces Cancer Risk in HCV+ Cirrhotics - (02/10/05)

4. Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma (liver cancer) - (02/09/05)

5. Early discontinuation of 'ineffective' anti-viral therapy may prove less popular with patients than with health care providers - (02/08/05)

6. Inapprorpriate Rejection for HCV Therapy for Psychiatric Disorder - (02/08/05)

7. Vitamin E Did Not Reduce Risk for Ribavirin-associated Anemia - (02/07/05)

8. Why HCV Therapy Is Not Utilized in Coinfection - (02/07/05)

9. Iron and Hepatitis C - (02/07/05)

10. Pegasys Approved for Coinfection in Europe - (02/03/05)

HEPATITIS B-

http://www.natap.org/hcv.htm

1. New insight on hepatitis B virus persistence from the study of intrahepatic viral cccDNA - (02/16/05)

2. Hepatitis B or Hepatitis C and HIV-infection Diagnosis/Care/Treatent - (02/11/05)

3. Study Finds Interferon Reduces Cancer Risk in HCV+ Cirrhotics - (02/10/05)

4. Long-term clinical and histological outcomes in patients with spontaneous hepatitis B surface antigen seroclearance - (02/10/05)

5. Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma (liver cancer) - (02/09/05)

6. The value and limitations of long-term nucleoside antiviral therapy in chronic hepatitis B - (02/09/05)

7. Liver & Kidney Transplant in HIV Study - (02/03/05)

8. Chronic Hepatitis B & HIV/HBV Coinfection - (01/31/05)

9. Hepatitis New Drug Research - (01/26/05)

10. Pegasys Receives Positive Opinion for HBV in Europe; HBV/HIV Coinfection Medical Management - (01/24/05)

Liver Transplantation-

http://www.natap.org/liverTran.htm

1. PegIntron+RBV for Recurrent HCV After Transplant - (02/01/05)

2. Pegasys for hepatitis C after liver transplantation: Two randomized, controlled trials - (01/25/05)

3. Liver transplantation in HIV-infected recipients - (01/13/05)

4. Liver transplantation in patients with HIV infection - (09/21/04)

5. Hepatitis C recurrence is more severe after living donor compared to cadaveric liver transplantation - (09/14/04)